Atlas Trials

Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients

Clinical trial NCT02209584 · COMPLETED

Trial details

NCT number
NCT02209584
Sponsor
Myriad Genetic Laboratories, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2014-05-01
Primary completion
2015-04-15
Enrollment
274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.